As climate change causes global temperatures to rise, heat-related illness, a potentially fatal condition in dogs, will become an ever-greater threat. this study aimed to report the incidence, fatality and canine risk factors of heat-related illness in UK dogs under primary veterinary care in 2016. The VetCompass tM programme collects de-identified electronic patient records from UK veterinary practices for research. From the clinical records of 905,543 dogs under veterinary care in 2016, 395 confirmed heat-related illness events were identified. The estimated 2016 incidence of heat-related illness was 0.04% (95% CI 0.04-0.05%), with an event fatality rate of 14.18% (95% CI 11.08-17.96%). Multivariable analysis identified significant risk factors including breed (e.g. Chow Chow, Bulldog and French Bulldog), higher bodyweight relative to the breed/sex mean and being over two years of age. Dogs with a brachycephalic skull shape and dogs weighing over 50 kg were also at greater risk. As we move into an ever-warmer world, veterinary professionals may need to include resistance to heat-related illness amongst their rationales when advising owners on breed selection. Breeding for good respiratory function and maintaining a healthy bodyweight should be considered key welfare priorities for all dogs to limit the risk of heat-related illness. Climate change is listed among the World Health Organisation's top ten threats to Global Health in 2019, with heat-related illness (HRI) predicted to contribute towards an additional 250,000 human deaths annually by 2030 1. HRI is a progressive disorder of animals and man caused by core body temperatures that rise above homeostatic limits, resulting in metabolic disturbances 2. This can lead to decreased cardiac output, fatigue of heat dissipation mechanisms, organ failure and ultimately death 2-4. Animal welfare organisations in the United Kingdom (UK) and Australia have reported increasing numbers of calls about animals trapped in hot environments over recent years 5,6. As the frequency and severity of heat waves is predicted to increase, there is an urgent need for better evidence-based guidance on the risk factors and early recognition of HRI to improve prevention and treatment strategies for both humans and animals 3,7. A deficiency of reliable and current data on the diagnosis, treatment and fatality rate of HRI is a key barrier to mitigating HRI risks in both humans and dogs 8. The classical terminology used to define HRI varies, but typically includes terms that describe progression from heat stress, through heat exhaustion to heatstroke 2. However, these classical terms lack clear explicit definitions and are often used interchangeably as synonyms, leaving their usage open to individual interpretation that creates a confused medical and veterinary literature 3. A novel HRI scoring system has been proposed for use in humans, acknowledging that patients can progress through the stages of disease severity depending on the duration and intensity of heat exposure and effectivenes...
Heat-related illness will affect increasing numbers of dogs as global temperatures rise unless effective mitigation strategies are implemented. This study aimed to identify the key triggers of heat-related illness in dogs and investigate canine risk factors for the most common triggers in UK dogs. Using the VetCompassTM programme, de-identified electronic patient records of 905,543 dogs under primary veterinary care in 2016 were reviewed to identify 1259 heat-related illness events from 1222 dogs. Exertional heat-related illness was the predominant trigger (74.2% of events), followed by environmental (12.9%) and vehicular confinement (5.2%). Canine and human risk factors appear similar; young male dogs had greater odds of exertional heat-related illness, older dogs and dogs with respiratory compromise had the greatest odds of environmental heat-related illness. Brachycephalic dogs had greater odds of all three types of heat-related illness compared with mesocephalic dogs. The odds of death following vehicular heat-related illness (OR 1.47, p = 0.492) was similar to that of exertional heat-related illness. In the UK, exertional heat-related illness affects more dogs, and kills more dogs, than confinement in a hot vehicle. Campaigns to raise public awareness about heat-related illness in dogs need to highlight that dogs don’t die just in hot cars.
Critical illness in COVID-19 is an extreme and clinically homogeneous disease phenotype that we have previously shown1 to be highly efficient for discovery of genetic associations2. Despite the advanced stage of illness at presentation, we have shown that host genetics in patients who are critically ill with COVID-19 can identify immunomodulatory therapies with strong beneficial effects in this group3. Here we analyse 24,202 cases of COVID-19 with critical illness comprising a combination of microarray genotype and whole-genome sequencing data from cases of critical illness in the international GenOMICC (11,440 cases) study, combined with other studies recruiting hospitalized patients with a strong focus on severe and critical disease: ISARIC4C (676 cases) and the SCOURGE consortium (5,934 cases). To put these results in the context of existing work, we conduct a meta-analysis of the new GenOMICC genome-wide association study (GWAS) results with previously published data. We find 49 genome-wide significant associations, of which 16 have not been reported previously. To investigate the therapeutic implications of these findings, we infer the structural consequences of protein-coding variants, and combine our GWAS results with gene expression data using a monocyte transcriptome-wide association study (TWAS) model, as well as gene and protein expression using Mendelian randomization. We identify potentially druggable targets in multiple systems, including inflammatory signalling (JAK1), monocyte–macrophage activation and endothelial permeability (PDE4A), immunometabolism (SLC2A5 and AK5), and host factors required for viral entry and replication (TMPRSS2 and RAB2A).
Prolonged and repetitive COVID-19 facility closures have led to an abrupt cessation of visitors within UK and Irish zoos for variable periods since March 2020. This study sought to increase understanding of the impact of closures and reopenings on animal behaviour, thereby broadening understanding of whether zoo animals habituate to visitors. Data were collected from June to August 2020 at two UK facilities on eight species (n = 1 Chinese goral, n = 2 Grevy’s zebra, n = 11 swamp wallaby, n = 2 Rothschild’s giraffe, n = 2 nyala, n = 4 Chapman’s zebra, n = 2 snow leopard and n = 3 Amur leopard). Behaviour change and enclosure use was variable across species but most changes were non-significant. Grevy’s zebra engaged in more comfort behaviour during closure periods than post-closure (p < 0.05). Chinese goral engaged in more environmental interactions during closure periods (p < 0.05). Grevy’s zebra spent longer than would be expected by chance closest to public viewing areas during closure periods (p < 0.008). These results suggest variable impacts of covid-19 closures and reopenings, mirroring human-animal interaction literature. We highlight the potential for some species to take longer to re-habituate to the presence of zoo visitors. As facility closures/reopenings are ongoing, we advocate a longitudinal monitoring approach. Furthermore, we recommend incorporation of physical and physiological measures of welfare where possible, alongside behavioural responses, to enable a holistic approach to answering fundamental questions on whether zoo animals habituate to visitors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.